Yin Liu, Ph.D.

Dr. Yin Liu has expertise and manages a grant portfolio in T cell exhaustion, Inflammation and tissue homeostasis in cancer, autoimmunity and immune-related adverse events (irAEs), lymphocyte migration, and T cell receptor signaling. 

Along with his work in DCB, Dr. Liu co-chairs a Cancer Moonshot Implementation Team. 

Research Programs:

Dr. Liu is involved in NCI research programs and a Cancer Moonshot initiative:

• Pediatric Immunotherapy Network (PIN)
• Pediatric Immunotherapy Discovery and Development Network (PI-DDN)
• NCI Serological Sciences Network for COVID-19 (SeroNet)
   

Background

Prior to his work as a DCB program director, Dr. Liu was a scientific review officer at  the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Before working as a science administrator, he was a scientist in the NIH intramural research program, where he was involved in research about T cell receptor signaling, regulation of lymphocyte cytoskeleton and lymphocyte migration, and autoinflammatory diseases caused by genetic mutations.

He came to DCB because of the opportunity to support the field of immunotherapy. 
 

Education

• Ph.D., Immunology, The Fourth Military Medical Institute